We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+29.99%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$620M
AUM Growth
+$89.5M
Cap. Flow
-$6.73M
Cap. Flow %
-1.09%
Top 10 Hldgs %
50.06%
Holding
57
New
1
Increased
7
Reduced
4
Closed
6

Top Buys

Rank Stock Value
1
BR icon
Broadridge
BR
+$1.67M
2
IBM icon
IBM
IBM
+$1.67M
3
SN icon
SharkNinja
SN
+$1.66M
4
UL icon
Unilever
UL
+$1.62M
5
AVGO icon
Broadcom
AVGO
+$1.55M

Top Sells

Rank Stock Value
1
CRSP icon
CRISPR Therapeutics
CRSP
+$4.44M
2
UBER icon
Uber
UBER
+$4.23M
3
AAPL icon
Apple
AAPL
+$2.86M
4
ALC icon
Alcon
ALC
+$2.07M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$982K

Sector Composition

Rank Sector Weight
1 Technology 39.25%
2 Industrials 19.29%
3 Consumer Discretionary 13.16%
4 Healthcare 9.57%
5 Communication Services 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARM icon
26
Arm
ARM
$285B
$8.6M 1.39%
24,250
– –
HD icon
27
Home Depot
HD
$338B
$8.26M 1.33%
23,415
– –
VLTO icon
28
Veralto
VLTO
$23B
$7.79M 1.26%
87,877
– –
PG icon
29
Procter & Gamble
PG
$349B
$7.73M 1.25%
52,710
– –
RTX icon
30
RTX Corp
RTX
$261B
$7.28M 1.17%
38,348
– –
SN icon
31
SharkNinja
SN
$21.9B
$6.9M 1.11%
45,315
+13,830
+44% +$1.66M
SYK icon
32
Stryker
SYK
$123B
$6.44M 1.04%
20,465
+1,790
+10% +$564K
IBM icon
33
IBM
IBM
$200B
$6.44M 1.04%
22,885
+6,625
+41% +$1.67M
LOW icon
34
Lowe's Companies
LOW
$117B
$6.2M 1%
28,100
– –
UL icon
35
Unilever
UL
$134B
$5.79M 0.94%
96,377
+27,940
+41% +$1.62M
GOOG icon
36
Alphabet (Google) Class C
GOOG
$4.22T
$5.35M 0.86%
15,135
– –
CSX icon
37
CSX Corp
CSX
$94.3B
$4.85M 0.78%
102,000
– –
AVGO icon
38
Broadcom
AVGO
$1.76T
$4.75M 0.77%
12,570
+3,870
+44% +$1.55M
CL icon
39
Colgate-Palmolive
CL
$74.4B
$4.69M 0.76%
51,200
– –
TILE icon
40
Interface
TILE
$1.92B
$3.59M 0.58%
100,155
– –
RKT icon
41
Rocket Companies
RKT
$41.1B
$2.51M 0.4%
159,135
– –
ABNB icon
42
Airbnb
ABNB
$86.6B
$2.51M 0.4%
17,510
+635
+4% +$86.6K
XOM icon
43
ExxonMobil
XOM
$611B
$2.24M 0.36%
16,400
– –
SOFI icon
44
SoFi Technologies
SOFI
$22.2B
$2.18M 0.35%
121,415
– –
ADBE icon
45
Adobe
ADBE
$94.3B
$1.85M 0.3%
9,000
– –
MRK icon
46
Merck
MRK
$315B
$1.79M 0.29%
13,950
– –
ZTS icon
47
Zoetis
ZTS
$32.1B
$1.78M 0.29%
24,818
– –
BR icon
48
Broadridge
BR
$17.3B
$1.52M 0.24%
+11,080
New +$1.67M
CI icon
49
Cigna
CI
$74.5B
$1.45M 0.23%
5,254
– –
NVDA icon
50
NVIDIA
NVDA
$4.91T
$1.25M 0.2%
6,225
-450
-7% -$92.5K
1
2
3

Similar funds

RC
RBO & Co Saint Helena, California $620M AUM 4.67% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $620M AUM 16.24% 1-Year Est. Return
KFAS
Keating Financial Advisory Services Manhattan, Kansas $619M AUM
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
RIS
Richmond Investment Services Mequon, Wisconsin $619M AUM 22.39% 1-Year Est. Return
AMG
Asset Management Group Stamford, Connecticut $619M AUM 15.97% 1-Year Est. Return
BWP
Burling Wealth Partners Chicago, Illinois $618M AUM 17.33% 1-Year Est. Return
MC
McMorgan & Co San Francisco, California $618M AUM 8.76% 1-Year Est. Return

Chad R. Baker's Q2 2026 Portfolio in Review

As of Q2 2026, Chad R. Baker held 57 positions worth $620M, up 17% from $530M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Chad R. Baker's Q2 2026 filing shows 1 new, 7 increased, 4 reduced and 6 closed positions. Its largest new stake was Broadridge: 11,080 shares worth $1.52M. The largest sale was CRISPR Therapeutics, an estimated $4.44M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 33% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Chad R. Baker's largest Q2 2026 buy was Broadridge: 11,080 shares worth $1.52M.
  • Chad R. Baker added most to IBM in Q2 2026, an estimated $1.67M increase.
  • Chad R. Baker's biggest Q2 2026 reduction was Apple, cutting an estimated $2.86M.
  • Chad R. Baker fully exited CRISPR Therapeutics in Q2 2026, selling an estimated $4.44M.
  • Chad R. Baker's ten largest holdings make up 50% of its $620M portfolio in Q2 2026.
  • Chad R. Baker opened 1 new position and closed 6 in Q2 2026.
  • Chad R. Baker's portfolio value rose 17% quarter-over-quarter to $620M.

Based on Chad R. Baker's 13F filing for Q2 2026, filed 16 Jul 2026.